biochemistri metabol pathway link seri chemic reaction occur within cell reactant product intermedi enzymat reaction know metabolit modifi sequenc chemic reaction catalyz enzym case metabol pathway product one enzym act substrat next howev side product consid wast remov cell enzym often requir dietari miner vitamin cofactor function differ metabol pathway function base posit within eukaryot cell signific pathway give compart cell instanc electron transport chain oxid phosphoryl take place mitochondri membran contrast glycolysi pentos phosphat pathway fatti acid biosynthesi occur cytosol cell two type metabol pathway character abil either synthes molecul util energi anabol pathway break complex molecul releas energi process catabol pathway two pathway complement energi releas one use degrad process catabol pathway provid energi requir conduct biosynthesi anabol pathway addit two distinct metabol pathway amphibol pathway either catabol anabol base need avail energi pathway requir mainten homeostasi within organ flux metabolit pathway regul depend need cell avail substrat end product pathway may use immedi initi anoth metabol pathway store later use metabol cell consist elabor network interconnect pathway enabl synthesi breakdown molecul anabol catabol metabol pathway consist seri biochem reaction connect intermedi product one reaction substrat subsequ reaction metabol pathway often consid flow one direct although chemic reaction technic revers condit cell often thermodynam favor flux proceed one direct reaction exampl one pathway may respons synthesi particular amino acid breakdown amino acid may occur via separ distinct pathway one exampl except rule metabol glucos glycolysi result breakdown glucos sever reaction glycolysi pathway revers particip resynthesi glucos gluconeogenesi catabol pathway seri reaction bring net releas energi form high energi phosphat bond form energi carrier adenosin diphosph adp guanosin diphosph gdp produc adenosin triphosph atp guanosin triphosph gtp respect net reaction therefor thermodynam favor result low free energi final product catabol pathway exergon system produc chemic energi form atp gtp nadh nadph fadh etc energi contain sourc carbohydr fat protein end product often carbon dioxid water ammonia coupl endergon reaction anabol cell synthes new macromolecul use origin precursor anabol pathway exampl coupl reaction phosphoryl fructosephosph form intermedi fructosebisphosph enzym phosphofructokinas accompani hydrolysi atp pathway glycolysi result chemic reaction within metabol pathway high thermodynam favor result irrevers cell fructos phosphat atp fructos bisphosph adp displaystyl ce fructosephosph atp fructosebisphosph adp core set energyproduc catabol pathway occur within live organ form pathway transfer energi releas breakdown nutrient atp small molecul use energi eg gtp nadph fadh cell perform anaerob respir glycolysi addit organ perform effici aerob respir citric acid cycl oxid phosphoryl addit plant alga cyanobacteria abl use sunlight anabol synthes compound nonliv matter photosynthesi contrast catabol pathway anabol pathway requir energi input construct macromolecul polypeptid nucleic acid protein polysaccharid lipid isol reaction anabol unfavor cell due posit gibb free energi thus input chemic energi coupl exergon reaction necessari coupl reaction catabol pathway affect thermodynam reaction lower overal activ energi anabol pathway allow reaction take place otherwis endergon reaction nonspontan anabol pathway biosynthet pathway mean combin small molecul form larg complex one exampl revers pathway glycolysi otherwis know gluconeogenesi occur liver sometim kidney maintain proper glucos concentr blood suppli brain muscl tissu adequ amount glucos although gluconeogenesi similar revers pathway glycolysi contain three distinct enzym glycolysi allow pathway occur spontan exampl pathway gluconeogenesi illustr imag titl gluconeogenesi mechan amphibol pathway one either catabol anabol base avail need energi currenc energi biolog cell adenosin triphosph atp store energi phosphoanhydrid bond energi util conduct biosynthesi facilit movement regul activ transport insid cell exampl amphibol pathway citric acid cycl glyoxyl cycl set chemic reaction contain energi produc util pathway right illustr amphibol properti tca cycl glyoxyl shunt pathway altern tricarboxyl acid tca cycl redirect pathway tca prevent full oxid carbon compound preserv high energi carbon sourc futur energi sourc pathway occur plant bacteria transpir absenc glucos molecul flux entir pathway regul ratedetermin step slow step network reaction ratelimit step occur near begin pathway regul feedback inhibit ultim control overal rate pathway metabol pathway cell regul coval noncoval modif coval modif involv addit remov chemic bond wherea noncoval modif also know alloster regul bind regul enzym via hydrogen bond electrostat interact van der waal forc rate turnov metabol pathway also know metabol flux regul base stoichiometr reaction model util rate metabolit transloc pace molecul across lipid bilay regul method base experi involv clabel analyz nuclear magnet reson nmr gas chromatographymass spectrometri gcmsderiv mass composit aforement techniqu synthes statist interpret mass distribut proteinogen amino acid catalyt activ enzym cell metabol pathway target clinic therapeut use within mitochondri metabol network instanc various pathway target compound prevent cancer cell prolifer one pathway oxid phosphoryl oxpho within electron transport chain etc various inhibitor downregul electrochem reaction take place complex ii iii iv therebi prevent format electrochem gradient downregul movement electron etc substratelevel phosphoryl occur atp synthas also direct inhibit prevent format atp necessari suppli energi cancer cell prolifer inhibitor lonidamin atovaquon inhibit complex ii complex iii respect current undergo clinic trial fdaapprov nonfdaapprov inhibitor still show experiment success vitro heme import prosthet group present complex ii iv also target sinc heme biosynthesi uptak correl increas cancer progress various molecul inhibit heme via differ mechan instanc succinylaceton show decreas heme concentr inhibit aminolevulin acid murin erthroleukemia cell primari structur hemesequester peptid hsp hsp modifi downregul heme concentr reduc prolifer nonsmal lung cancer cell tricarboxyl acid cycl tca glutaminolysi also target cancer treatment sinc essenti surviv prolifer cancer cell ivosidenib enasidenib two fdaapprov cancer treatment arrest tca cycl cancer cell inhibit isocitr dehydrogenas idh isocitr dehydrogenas idh respect ivosidenib specif acut myeloma leukemia aml cholangiocarcinoma wherea enasidenib specif acut myeloma leukemia aml clinic trial consist adult patient cholangiocarcinoma idh mutat statist signific improv hr patient random ivosidenib still advers side effect patient includ fatigu nausea diarrhea decreas appetit ascit anemia clinic trial consist adult patient aml idh mutat patient experi complet respons cr complet respons partial hematolog recoveri crh last median month enasidenib patient requir transfus begin trial long requir transfus day time period enasidenib patient requir transfus begin trial still requir transfus end trial side effect enasidenib includ nausea diarrhea elev bilirubin notabl differenti syndrom glutaminas gl enzym respons convert glutamin glutam via hydrolyt deamid first reaction glutaminolysi also target recent year mani small molecul azaserin acivicin cb show inhibit glutaminas thus reduc cancer cell viabil induc apoptosi cancer cell due effect antitumor abil sever cancer type ovarian breast lung cancer cb gl inhibitor current undergo clinic studi fdaapprov